BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6707191)

  • 1. Metabolism of neurotensin and pancreatic polypeptide in man: role of the kidney and plasma factors.
    Shulkes A; Bijaphala S; Dawborn JK; Fletcher DR; Hardy KJ
    J Clin Endocrinol Metab; 1984 May; 58(5):873-9. PubMed ID: 6707191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
    Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
    J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolism of intravenously infused neurotensin in man and its chromatographic characterization in human plasma.
    Lee YC; Allen JM; Uttenthal LO; Walker MC; Shemilt J; Gill SS; Bloom SR
    J Clin Endocrinol Metab; 1984 Jul; 59(1):45-50. PubMed ID: 6725524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ and plasma metabolism of neurotensin in sheep.
    Shulkes A; Fletcher DR; Hardy KJ
    Am J Physiol; 1983 Nov; 245(5 Pt 1):E457-62. PubMed ID: 6638173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological potency of neurotensin metabolites in vivo: importance of alcohol 'fixation' of blood.
    Shulkes A; Fletcher DR; Hardy KJ
    J Gastroenterol Hepatol; 1989; 4(5):429-35. PubMed ID: 2491208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma neurotensin in the conscious pig: release by individual food components and effects on exocrine pancreas secretion.
    Cuber JC; Philippe C; Abello J; Corring T; Levenez F; Chayvialle JA
    Pancreas; 1990 May; 5(3):306-13. PubMed ID: 2343043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of neurotensin by isolated perfused rat kidney.
    Gillatt DJ; Shulkes A; Read DM; Hardy KJ
    Am J Physiol; 1990 Jun; 258(6 Pt 1):E930-6. PubMed ID: 2360626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin metabolism in the rat: contribution of the kidney.
    Shulkes A; Englin I; Read D; Hardy KJ
    Peptides; 1987; 8(6):961-5. PubMed ID: 3126491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and metabolism of neurotensin in man.
    Pedersen JH; Andersen HO; Olsen PS; Henriksen JH
    J Clin Endocrinol Metab; 1989 Feb; 68(2):294-300. PubMed ID: 2918048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stability and metabolism of intravenously administered neurotensin in the rat.
    Aronin N; Carraway RE; Ferris CF; Hammer RA; Leeman SE
    Peptides; 1982; 3(4):637-42. PubMed ID: 7134032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic metabolism of neurotensin.
    Brook CW; Shulkes A; Sewell RB; Smallwood RA
    Endocrinology; 1987 Apr; 120(4):1397-402. PubMed ID: 3549259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin-like immunoreactivities in human plasma: feeding responses and metabolism.
    Holst Pedersen J; Fahrenkrug J
    Peptides; 1986; 7(1):15-20. PubMed ID: 3714532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of plasma neurotensinlike immunoreactivity after a meal. Characterization of the elevated components.
    Hammer RA; Carraway RE; Leeman SE
    J Clin Invest; 1982 Jul; 70(1):74-81. PubMed ID: 7085889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of neurotensin in endocrine tumors.
    Kapuscinski M; Shulkes A; Read D; Hardy KJ
    J Clin Endocrinol Metab; 1990 Jan; 70(1):100-6. PubMed ID: 2403568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intact neurotensin (NT) in human plasma: response to oral feeding.
    Shaw C; Buchanan KD
    Regul Pept; 1983 Oct; 7(2):145-53. PubMed ID: 6197723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of renal failure or portacaval shunt on release of neurotensin in man.
    Eaves ER; Hansky J
    Dig Dis Sci; 1987 Jan; 32(1):28-32. PubMed ID: 3792180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral fat on plasma levels of neurotensin and neurotensin fragments in humans. Characterization by high-pressure liquid chromatography.
    Draviam EJ; Upp JR; Greeley GH; Townsend CM; Thompson JC
    Dig Dis Sci; 1990 Feb; 35(2):200-4. PubMed ID: 2302977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line.
    Bidard JN; de Nadai F; Rovere C; Moinier D; Laur J; Martinez J; Cuber JC; Kitabgi P
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):225-33. PubMed ID: 8471039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin infusion in man: pharmacokinetics and effect on gastrointestinal and pituitary hormones.
    Blackburn AM; Fletcher DR; Adrian TE; Bloom SR
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1257-61. PubMed ID: 7002947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin in plasma: immunochemical and chromatographic character of acid/acetone-soluble material.
    Carraway R; Hammer RA; Leeman SE
    Endocrinology; 1980 Aug; 107(2):400-6. PubMed ID: 7389661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.